Otto Bock HealthCare

Ottobock develops and sells prosthetic and orthotic components, neuro-orthotics, exoskeletons and mobility aids. It sells to orthopedic clinics and healthcare providers (B2B) and to patients through its own patient-care network (B2C). That network has over 430 clinics, and the company operates in 45 countries. Group revenue was about €1.68 billion in 2025, and H1 2026 core revenue rose 7.7% to €818.5 million. The company has about 9,300 FTEs, is listed on the stock exchange (OBCK) and is majority-owned by Näder Holding. It was founded in Berlin in 1919 and is run from Duderstadt.